We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-3.47%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$5.47B
Cap. Flow
+$963M
Cap. Flow %
0.81%
Top 10 Hldgs %
23.93%
Holding
4,385
New
262
Increased
2,061
Reduced
1,644
Closed
273

Sector Composition

Rank Sector Weight
1 Technology 14.55%
2 Financials 8.81%
3 Healthcare 8.45%
4 Industrials 6.22%
5 Consumer Discretionary 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRPT icon
3376
Freshpet
FRPT
$3.5B
$316K ﹤0.01%
3,078
-205
-6% -$19.3K
VAC icon
3377
Marriott Vacations Worldwide
VAC
$4.17B
$316K ﹤0.01%
2,004
+113
+6% +$18.2K
BTG icon
3378
CALL
B2Gold
BTG
$6.7B
$315K ﹤0.01%
318,500
+101,500
+47% +$408K
NEWP
3379
New Pacific Metals
NEWP
$1.24B
$315K ﹤0.01%
99,181
+36,197
+57% +$111K
OSUR icon
3380
OraSure Technologies
OSUR
$277M
$315K ﹤0.01%
46,397
+377
+0.8% +$3.01K
GOGL
3381
DELISTED
Golden Ocean Group
GOGL
$314K ﹤0.01%
25,379
+12,026
+90% +$131K
SLX icon
3382
VanEck Steel ETF
SLX
$174M
$314K ﹤0.01%
4,632
-291
-6% -$17.2K
UUU icon
3383
Universal Safety Products Inc
UUU
$10.3M
$312K ﹤0.01%
73,513
WPRT
3384
PUT
Westport Fuel Systems
WPRT
$32.7M
$312K ﹤0.01%
8,620
+1,340
+18% +$23.9K
COKE icon
3385
Coca-Cola Consolidated
COKE
$12.7B
$311K ﹤0.01%
6,250
-2,150
-26% -$116K
GDEN
3386
DELISTED
Golden Entertainment
GDEN
$311K ﹤0.01%
5,349
-1,404
-21% -$71.9K
PTCT icon
3387
PTC Therapeutics
PTCT
$6.01B
$311K ﹤0.01%
8,341
+1,243
+18% +$47.9K
BRC icon
3388
Brady Corp
BRC
$4.43B
$310K ﹤0.01%
6,699
-200
-3% -$9.76K
CSR
3389
Centerspace
CSR
$939M
$309K ﹤0.01%
3,146
+111
+4% +$10.8K
GDXJ icon
3390
CALL
VanEck Junior Gold Miners ETF
GDXJ
$8.33B
$309K ﹤0.01%
88,300
+25,700
+41% +$1.1M
NNY icon
3391
Nuveen New York Municipal Value Fund
NNY
$158M
$309K ﹤0.01%
34,255
+3,000
+10% +$28.3K
NTB icon
3392
Bank of N.T. Butterfield & Son
NTB
$2.51B
$309K ﹤0.01%
+8,603
New +$326K
DLX icon
3393
Deluxe
DLX
$1.11B
$308K ﹤0.01%
10,184
+228
+2% +$7.16K
PTR
3394
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$308K ﹤0.01%
6,087
-3,813
-39% -$194K
DNOW icon
3395
DNOW Inc
DNOW
$2.95B
$307K ﹤0.01%
27,847
-15,914
-36% -$154K
KOP icon
3396
Koppers
KOP
$874M
$307K ﹤0.01%
11,169
+2,101
+23% +$62K
NRO
3397
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
$307K ﹤0.01%
64,423
+403
+0.6% +$1.85K
NTST
3398
NETSTREIT Corp
NTST
$2.09B
$307K ﹤0.01%
13,693
+2,092
+18% +$46.4K
BIZD icon
3399
VanEck BDC Income ETF
BIZD
$1.71B
$306K ﹤0.01%
17,075
+5,858
+52% +$103K
ATEC icon
3400
Alphatec Holdings
ATEC
$1.51B
$305K ﹤0.01%
26,550
-2,232
-8% -$24.1K

Similar funds

Raymond James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Raymond James & Associates held 4,385 positions worth $119B, down 4.4% from $124B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2022 filing shows 262 new, 2,061 increased, 1,644 reduced and 273 closed positions. Its largest new stake was Shell: 688,334 shares worth $37.8M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $172M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2022 buy was Shell: 688,334 shares worth $37.8M.
  • Raymond James & Associates added most to Broadcom in Q1 2022, an estimated $236M increase.
  • Raymond James & Associates's biggest Q1 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $172M.
  • Raymond James & Associates fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $154M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $119B portfolio in Q1 2022.
  • Raymond James & Associates opened 262 new positions and closed 273 in Q1 2022.
  • Raymond James & Associates's portfolio value fell 4.4% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.